Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2025-12-28 @ 12:02 PM
Study NCT ID:
NCT04964050
Status:
WITHDRAWN
Last Update Posted:
2023-01-27
First Post:
2021-07-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-21
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-05-26
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-05-26
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-06
First Submit QC Date:
None
Study First Post Date:
2021-07-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-25
Last Update Post Date:
2023-01-27
Last Update Post Date Type:
ACTUAL